100s of titles, one news app for just $10 a month.
Dive Deeper:
Recap: Halozyme Therapeutics Q1 Earnings
Halozyme Therapeutics (NASDAQ:HALO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need…
Recap: Aptevo Therapeutics Q1 Earnings
Aptevo Therapeutics (NASDAQ:APVO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need…
Recap: Aclaris Therapeutics Q1 Earnings
Aclaris Therapeutics (NASDAQ:ACRS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need…
Recap: Revance Therapeutics Q1 Earnings
Revance Therapeutics (NASDAQ:RVNC) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need…
One subscription that gives you access to news from hundreds of sites
Recap: Onconova Therapeutics Q1 Earnings
Onconova Therapeutics (NASDAQ:ONTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need…
Recap: Cidara Therapeutics Q1 Earnings
Cidara Therapeutics (NASDAQ:CDTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need…
Get all your news in one place
Latest Business news:
How a Trash-Talking Crypto Bro Caused a $40 Billion Crash
Do Kwon, a trash-talking entrepreneur from South Korea, called the cryptocurrency he created in 2018 “my greatest invention.” In countless…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Google’s Russian business plans to file for bankruptcy
Google says its Russian subsidiary is planning to file for bankruptcy because it can't pay staff and suppliers. Russian state…
SA moves to scrap tax on electric vehicles
South Australia's new Labor government has delivered on one of its election promises and moved to scrap plans for a…
Crypto billionaire Sam Bankman-Fried: ‘I got involved with no clue what a blockchain was’
The FTX founder on hype, the problem with bitcoin and how crypto can build a fairer financial system
Wall Street stocks tumble following weak results from retailers
New York (AFP) - Wall Street stocks suffered one of their worst batterings since 2020 on Wednesday, as downcast earnings…
From analysis to good news, read the world’s best news in one place
Elon Musk loses $12 billion in a day as he tweets politics, slams ESG
Elon Musk said he’d supported Democrats in the past because “they were (mostly) the kindness party,” but has now changed…
EU policy aims for Big Tech ‘gatekeepers’
The European Union’s Digital Markets Act is a bold, innovative attempt to do what no power has successfully done: mitigate…

Recap: RAPT Therapeutics Q1 Earnings

By Benzinga Insights

 

RAPT Therapeutics (NASDAQ:RAPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

RAPT Therapeutics missed estimated earnings by 1.47%, reporting an EPS of $-0.69 versus an estimate of $-0.68.

Revenue was down $581.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 0.21% increase in the share price the next day.

Here's a look at RAPT Therapeutics's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.66 -0.62 -0.67 -0.71
EPS Actual -0.61 -0.63 -0.63 -0.66
Revenue Estimate 700.00K 780.00K 950.00K 870.00K
Revenue Actual 756.00K 966.00K 869.00K 1.22M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for RAPT Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Recap: Halozyme Therapeutics Q1 Earnings
Halozyme Therapeutics (NASDAQ:HALO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need…
Recap: Aptevo Therapeutics Q1 Earnings
Aptevo Therapeutics (NASDAQ:APVO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need…
Recap: Aclaris Therapeutics Q1 Earnings
Aclaris Therapeutics (NASDAQ:ACRS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need…
Recap: Revance Therapeutics Q1 Earnings
Revance Therapeutics (NASDAQ:RVNC) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need…
One subscription that gives you access to news from hundreds of sites
Recap: Onconova Therapeutics Q1 Earnings
Onconova Therapeutics (NASDAQ:ONTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need…
Recap: Cidara Therapeutics Q1 Earnings
Cidara Therapeutics (NASDAQ:CDTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need…
Get all your news in one place